Episode Details

J.C. Ruffalo: How to Successfully Launch a Medtech Startup

Ep. 17

Medtech entrepreneurship is on the rise, and for good reason. The continual growth that’s seen within the life sciences industry in Orange County has been attracting an increasing number of international investors and VC firms. Venture capital firms have set their sights on the Southern California life sciences industry, which is displayed by the fact that the amount of VC investment for 2018 was around $7.6 billion for biotech and medical devices. It's a good time to be involved in the startup scene. Yet entering the world of MedTech startups is complex and rife with unique challenges. When 90% of startups fail, what does one need to know about the 10% that don't? What are the best practices to cover blind spots one may have when launching a MedTech startup?

In this episode of DeviceAlliance’s Medtech Radio, we speak with the Director of LaunchPad & Investor Relations at OCTANe OC, J.C. Ruffalo. Join us as we discuss how to properly launch your startup Medtech company, creating a cohesive business plan, and amplify your capital funding strategy. Learn insight from over 600 successful LaunchPad Alumni since 2010, and discover why LaunchPad ranks in the top 5 out of over 900 SBDCs in the United States.

17

Follow the great work J.C. and team are doing at Octane OC.

Book Recommendation:

Thanks for listening! Please share our podcast on LinkedIn, Twitter, and Facebook, and stay tuned for our next episode!

OTHER MEDTECH RADIO EPISODES

  • All
  • Entrepreneurship/Startups
  • Leadership Spotlight
  • Marketing & Product Development
  • Professional Development
  • Women in MedTech
  • Young Professionals

Live DA Event: Critical Thinking on Clinical Trial Success | Ep.43

You’ve got a great idea for a medical device!  Now what? Most errors in clinical trials are a result of poor planning. Fancy statistical methods cannot rescue design flaws. Thus careful planning with clear foresight is absolutely crucial for clinical trial success.   With the explosion of Medtech opportunities for startups, what are the current